Leonard L Mazur - Net Worth and Insider Trading
Leonard L Mazur Net Worth
The estimated net worth of Leonard L Mazur is at least $5 Million dollars as of 2024-11-13. Leonard L Mazur is the Executive Chairman, 10% Owner of Citius Pharmaceuticals Inc and owns about 10,255,343 shares of Citius Pharmaceuticals Inc (CTXR) stock worth over $5 Million. Leonard L Mazur is also the Director of Tharimmune Inc and owns about 330 shares of Tharimmune Inc (THAR) stock worth over $723. Details can be seen in Leonard L Mazur's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Leonard L Mazur has not made any transactions after 2022-01-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Leonard L Mazur
Leonard L Mazur Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Leonard L Mazur owns 3 companies in total, including Citius Pharmaceuticals Inc (CTXR) , Gadsden Properties Inc (FCRE) , and Tharimmune Inc (THAR) .
Click here to see the complete history of Leonard L Mazur’s form 4 insider trades.
Insider Ownership Summary of Leonard L Mazur
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTXR | Citius Pharmaceuticals Inc | 2023-10-10 | director & 10 percent owner & Chief Executive Officer |
| FCRE | Gadsden Properties Inc | 2011-06-30 | director |
| THAR | Tharimmune Inc | 2022-01-14 | director |
Leonard L Mazur Latest Holdings Summary
Leonard L Mazur currently owns a total of 2 stocks. Among these stocks, Leonard L Mazur owns 10,255,343 shares of Citius Pharmaceuticals Inc (CTXR) as of September 27, 2019, with a value of $5 Million and a weighting of 99.99%. Leonard L Mazur also owns 330 shares of Tharimmune Inc (THAR) as of January 14, 2022, with a value of $723 and a weighting of 0.01%.
Latest Holdings of Leonard L Mazur
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTXR | Citius Pharmaceuticals Inc | 2019-09-27 | 10,255,343 | 0.48 | 4,905,131 |
| THAR | Tharimmune Inc | 2022-01-14 | 330 | 2.19 | 723 |
Holding Weightings of Leonard L Mazur
Leonard L Mazur Form 4 Trading Tracker
According to the SEC Form 4 filings, Leonard L Mazur has made a total of 0 transactions in Citius Pharmaceuticals Inc (CTXR) over the past 5 years. The most-recent trade in Citius Pharmaceuticals Inc is the acquisition of 2,234,700 shares on September 27, 2019, which cost Leonard L Mazur around $2 Million.
According to the SEC Form 4 filings, Leonard L Mazur has made a total of 1 transactions in Tharimmune Inc (THAR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tharimmune Inc is the acquisition of 67 shares on January 14, 2022, which cost Leonard L Mazur around $100,000.
Insider Trading History of Leonard L Mazur
- 1
Leonard L Mazur Trading Performance
GuruFocus tracks the stock performance after each of Leonard L Mazur's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leonard L Mazur is 8.39%. GuruFocus also compares Leonard L Mazur's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leonard L Mazur within 3 months outperforms 4 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Leonard L Mazur's insider trading performs compared to the benchmark.
Performance of Leonard L Mazur
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.18 | | | | | |
| Relative Return to S&P 500(%) | 0.47 | | | | | |
Leonard L Mazur Ownership Network
Ownership Network List of Leonard L Mazur
Ownership Network Relation of Leonard L Mazur
Leonard L Mazur Owned Company Details
What does Citius Pharmaceuticals Inc do?
Who are the key executives at Citius Pharmaceuticals Inc?
Leonard L Mazur is the director & 10 percent owner & Chief Executive Officer of Citius Pharmaceuticals Inc. Other key executives at Citius Pharmaceuticals Inc include director & Vice Chairman Myron Z Holubiak , Chief Financial Officer Jaime Bartushak , and Chief Medical Officer Myron Czuczman .
Citius Pharmaceuticals Inc (CTXR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Citius Pharmaceuticals Inc (CTXR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Citius Pharmaceuticals Inc (CTXR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Citius Pharmaceuticals Inc (CTXR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Citius Pharmaceuticals Inc Insider Transactions
Leonard L Mazur Mailing Address
Above is the net worth, insider trading, and ownership report for Leonard L Mazur. You might contact Leonard L Mazur via mailing address: C/o Citius Pharmaceuticals, Inc., 11 Commerce Drive, 1st Floor, Cranford Nj 07016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
